vimarsana.com

Latest Breaking News On - Elixinol global ltd - Page 5 : vimarsana.com

Global Cannabidiol (CBD) Market Size to Grow at a CAGR of 51% from 2021 to 2030

Share: Pune, India, June 01, 2021 (GLOBE NEWSWIRE) The global cannabidiol (CBD) market has been estimated to reach USD 2,740 million in 2021 and is projected to grow at a CAGR of around 51% during the forecast period till 2030. The demand for CBD-based products is growing due to their healing properties for various health conditions and medical disorders. Heart diseases, cancer, anxiety, depression, pain relief, and inflammation are some health conditions that can be potentially treated using cannabidiol products. Cannabidiol (CBD) is one of the 113 cannabinoids identified in the cannabis plant. The CBD-based products include oil, dried cannabis, capsules, and liquid solution. The products can be consumed in multiple ways like inhaling smoke or vapor and eating.

CBD-infused Cosmetics Market: COVID-19 Focused Report|Featuring Cronos Group Inc , Elixinol Global Ltd among others|Technavio

NEW YORK, May 26, 2021 /PRNewswire/ The CBD-infused cosmetics market is expected to grow by USD 2.22 billion during 2020-2024, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the CBD-infused cosmetics market in optimistic, probable, and pessimistic forecast scenarios. Technavio s in-depth market research reports include value chain analysis and validation techniques to help industry leaders improve their business. - Advertisement - The CBD-infused cosmetics market will witness a positive impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio s pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020.

CBD-infused Cosmetics Market: COVID-19 Focused Report|Featuring Cronos Group Inc , Elixinol Global Ltd among others

Elixinol Wellness Ltd s core priorities to reignite US and UK businesses and integrate CannaCare as it fuels Canobo growth

Elixinol Wellness Ltd’s (ASX:EXL) (OTCQB:ELLXF) (FRA:E8M) core priorities are to reignite its US and UK businesses following the severe COVID-19 restrictions and integrate recently-acquired CannaCare into the Elixinol Group whilst fuelling the Canobo growth.  It is also targeting shifting its business to digital and optimise cost and margins as it transforms into a world-leading hemp-derived, natural health and wellness consumer products business.  The company, which has undergone a substantial evolution over the past 12 months, believes the management team’s strengthened strategic, commercial and governance capabilities positions it perfectly for the next phase in its development. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.